MA45539A - Dihydropyranopyrimidines pour le traitement d'infections virales - Google Patents
Dihydropyranopyrimidines pour le traitement d'infections viralesInfo
- Publication number
- MA45539A MA45539A MA045539A MA45539A MA45539A MA 45539 A MA45539 A MA 45539A MA 045539 A MA045539 A MA 045539A MA 45539 A MA45539 A MA 45539A MA 45539 A MA45539 A MA 45539A
- Authority
- MA
- Morocco
- Prior art keywords
- dihydropyranopyrimidines
- treatment
- viral infections
- infections
- viral
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
- C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
- C07D491/04—Ortho-condensed systems
- C07D491/044—Ortho-condensed systems with only one oxygen atom as ring hetero atom in the oxygen-containing ring
- C07D491/052—Ortho-condensed systems with only one oxygen atom as ring hetero atom in the oxygen-containing ring the oxygen-containing ring being six-membered
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/02—Local antiseptics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/04—Immunostimulants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmacology & Pharmacy (AREA)
- Immunology (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP16177401 | 2016-07-01 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| MA45539A true MA45539A (fr) | 2019-05-08 |
Family
ID=56292567
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MA045539A MA45539A (fr) | 2016-07-01 | 2017-06-30 | Dihydropyranopyrimidines pour le traitement d'infections virales |
Country Status (10)
| Country | Link |
|---|---|
| US (2) | US11053256B2 (fr) |
| EP (1) | EP3478688A1 (fr) |
| JP (1) | JP7171444B2 (fr) |
| CN (1) | CN109476675B (fr) |
| AU (1) | AU2017289418B2 (fr) |
| CA (1) | CA3027471A1 (fr) |
| IL (1) | IL263972A (fr) |
| MA (1) | MA45539A (fr) |
| SG (1) | SG11201811448RA (fr) |
| WO (1) | WO2018002319A1 (fr) |
Families Citing this family (42)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ES2691745T3 (es) | 2011-04-08 | 2018-11-28 | Janssen Sciences Ireland Uc | Derivados de pirimidina para el tratamiento de infecciones víricas |
| EP3722297A1 (fr) | 2015-03-04 | 2020-10-14 | Gilead Sciences, Inc. | Composés modulateurs de récepteurs de type toll |
| CA3027471A1 (fr) * | 2016-07-01 | 2018-01-04 | Janssen Sciences Ireland Unlimited Company | Dihydropyranopyrimidines pour le traitement d'infections virales |
| EP3507288B1 (fr) | 2016-09-02 | 2020-08-26 | Gilead Sciences, Inc. | Dérivés de 4,6-diamino-pyrido[3,2-d]pyrimidine en tant que modulateurs du recepteur de type toll |
| PL3507276T3 (pl) | 2016-09-02 | 2022-02-21 | Gilead Sciences, Inc. | Związki modulatory receptorów toll-podobnych |
| EA038646B1 (ru) | 2016-09-29 | 2021-09-28 | Янссен Сайенсиз Айрлэнд Анлимитед Компани | Пиримидиновые пролекарства для лечения вирусных инфекций и других заболеваний |
| JP6811857B2 (ja) | 2016-10-14 | 2021-01-13 | プレシジョン バイオサイエンシズ，インク． | Ｂ型肝炎ウイルスゲノムの認識配列に特異的な遺伝子操作メガヌクレアーゼ |
| US10966999B2 (en) | 2017-12-20 | 2021-04-06 | Institute Of Organic Chemistry And Biochemistry Ascr, V.V.I. | 3′3′ cyclic dinucleotides with phosphonate bond activating the sting adaptor protein |
| JP7098748B2 (ja) | 2017-12-20 | 2022-07-11 | インスティチュート オブ オーガニック ケミストリー アンド バイオケミストリー エーエスシーアール，ヴイ．ヴイ．アイ． | Ｓｔｉｎｇアダプタータンパク質を活性化するホスホン酸結合を有する２’３’環状ジヌクレオチド |
| US10836769B2 (en) | 2018-02-26 | 2020-11-17 | Gilead Sciences, Inc. | Substituted pyrrolizine compounds and uses thereof |
| TW201945003A (zh) | 2018-03-01 | 2019-12-01 | 愛爾蘭商健生科學愛爾蘭無限公司 | ２，４－二胺基喹唑啉衍生物及其醫學用途 |
| EP3774883A1 (fr) | 2018-04-05 | 2021-02-17 | Gilead Sciences, Inc. | Anticorps et leurs fragments qui se lient à la protéine x du virus de l'hépatite b |
| TW202005654A (zh) | 2018-04-06 | 2020-02-01 | 捷克科學院有機化學與生物化學研究所 | ２，２，─環二核苷酸 |
| TWI818007B (zh) | 2018-04-06 | 2023-10-11 | 捷克科學院有機化學與生物化學研究所 | 2'3'-環二核苷酸 |
| TWI833744B (zh) | 2018-04-06 | 2024-03-01 | 捷克科學院有機化學與生物化學研究所 | 3'3'-環二核苷酸 |
| US11142750B2 (en) | 2018-04-12 | 2021-10-12 | Precision Biosciences, Inc. | Optimized engineered meganucleases having specificity for a recognition sequence in the Hepatitis B virus genome |
| TW202014193A (zh) | 2018-05-03 | 2020-04-16 | 捷克科學院有機化學與生物化學研究所 | 包含碳環核苷酸之2’3’－環二核苷酸 |
| WO2020028097A1 (fr) | 2018-08-01 | 2020-02-06 | Gilead Sciences, Inc. | Formes solides d'acide (r)-11-(méthoxyméthyl)-12-(3-méthoxypropoxy)-3,3-diméthyl-8-0 x0-2,3,8,13b-tétrahydro-1h-pyrido[2,1-a] pyrrolo[1,2-c]phtalazine-7-carboxylique |
| UA126619C2 (uk) | 2018-10-31 | 2022-11-02 | Гіліад Сайєнсіз, Інк. | Заміщені сполуки 6-азабензімідазолу як інгібітори hpk1 |
| AU2019373221B2 (en) | 2018-10-31 | 2022-05-26 | Gilead Sciences, Inc. | Substituted 6-azabenzimidazole compounds having HPK1 inhibitory activity |
| JP7287708B2 (ja) | 2019-02-08 | 2023-06-06 | プロジェニア インコーポレイテッド | Ｔｏｌｌ－ｌｉｋｅ受容体７または８アゴニストとコレステロールの結合体およびその用途 |
| DK3934757T3 (da) | 2019-03-07 | 2023-04-17 | Inst Of Organic Chemistry And Biochemistry Ascr V V I | 2'3'-cykliske dinukleotider og prodrugs deraf |
| JP7350872B2 (ja) | 2019-03-07 | 2023-09-26 | インスティチュート オブ オーガニック ケミストリー アンド バイオケミストリー エーエスシーアール，ヴイ．ヴイ．アイ． | ３’３’－環状ジヌクレオチドおよびそのプロドラッグ |
| EP3935065A1 (fr) | 2019-03-07 | 2022-01-12 | Institute of Organic Chemistry and Biochemistry ASCR, V.V.I. | Analogue du dinucléotide 3'3'-cyclique comprenant un nucléotide modifié par cyclopentanyle utilisé en tant que modulateur de sting |
| TWI751517B (zh) | 2019-04-17 | 2022-01-01 | 美商基利科學股份有限公司 | 類鐸受體調節劑之固體形式 |
| TWI751516B (zh) | 2019-04-17 | 2022-01-01 | 美商基利科學股份有限公司 | 類鐸受體調節劑之固體形式 |
| EP3972695A1 (fr) | 2019-05-23 | 2022-03-30 | Gilead Sciences, Inc. | Exo-méthylène-oxindoles substitués qui sont des inhibiteurs de hpk1/map4k1 |
| TW202115056A (zh) | 2019-06-28 | 2021-04-16 | 美商基利科學股份有限公司 | 類鐸受體調節劑化合物的製備方法 |
| WO2021034804A1 (fr) | 2019-08-19 | 2021-02-25 | Gilead Sciences, Inc. | Formulations pharmaceutiques de ténofovir alafénamide |
| KR20220074917A (ko) | 2019-09-30 | 2022-06-03 | 길리애드 사이언시즈, 인코포레이티드 | Hbv 백신 및 hbv를 치료하는 방법 |
| EP4069729B1 (fr) | 2019-12-06 | 2025-01-22 | Precision BioSciences, Inc. | Méganucléases modifiées optimisées ayant une spécificité pour une séquence de reconnaissance dans un génome du virus de l'hépatite b |
| US20230100429A1 (en) | 2020-03-02 | 2023-03-30 | Progeneer Inc. | Live-pathogen-mimetic nanoparticles based on pathogen cell wall skeleton, and production method thereof |
| CA3169348A1 (fr) | 2020-03-20 | 2021-09-23 | Gilead Sciences, Inc. | Promedicaments de nucleosides de 4'-c-substitue-2-halo-2'-desoxyadenosine et leurs procedes de fabrication et d'utilisation |
| WO2022031057A1 (fr) | 2020-08-04 | 2022-02-10 | 성균관대학교산학협력단 | Conjugué d'un médicament fonctionnel et d'un agoniste de récepteur de type toll 7 ou 8, dont le site actif est temporairement inactivé et utilisation associée |
| JP2023536945A (ja) | 2020-08-04 | 2023-08-30 | プロジェニア インコーポレイテッド | 動力学的に作用するアジュバントアンサンブル |
| EP4194006A4 (fr) | 2020-08-04 | 2024-12-04 | Progeneer Inc. | Vaccin à arnm comprenant un adjuvant permettant un contrôle cinétique |
| WO2022241134A1 (fr) | 2021-05-13 | 2022-11-17 | Gilead Sciences, Inc. | Combinaison d'un composé de modulation de tlr8 et agent thérapeutique anti-arnsi de vhb |
| EP4359411A1 (fr) | 2021-06-23 | 2024-05-01 | Gilead Sciences, Inc. | Composés modulant les diacylglycérol kinases |
| WO2022271684A1 (fr) | 2021-06-23 | 2022-12-29 | Gilead Sciences, Inc. | Composés modulant les diacylglycérol kinases |
| JP2024520593A (ja) | 2021-06-23 | 2024-05-24 | ギリアード サイエンシーズ， インコーポレイテッド | ジアシルグリエルコール（ｄｉａｃｙｌｇｌｙｅｒｃｏｌ）キナーゼ調節化合物 |
| CN117396478A (zh) | 2021-06-23 | 2024-01-12 | 吉利德科学公司 | 二酰基甘油激酶调节化合物 |
| US20240132464A1 (en) * | 2022-09-28 | 2024-04-25 | Accutar Biotechnology Inc. | Heterocyclic compounds as e3 ligase inhibitors |
Family Cites Families (90)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2610889B2 (ja) | 1987-09-03 | 1997-05-14 | 日本臓器製薬株式会社 | 新規架橋アデニン誘導体 |
| JP3650398B2 (ja) * | 1993-08-19 | 2005-05-18 | ジヤンセン・フアーマシユーチカ・ナームローゼ・フエンノートシヤツプ | 血管収縮性置換ジヒドロピラノピリジン |
| EP0882727B9 (fr) | 1996-07-03 | 2005-06-15 | Sumitomo Pharmaceuticals Company, Limited | Nouveaux derives de purine |
| NZ333302A (en) | 1996-08-28 | 2000-08-25 | Pfizer | Substituted 6,5-hetero-bicyclic derivatives for the prevention or inhibition of a disorder that can be treated by antagonising corticotropin releasing factor |
| EP0989129B1 (fr) | 1996-10-04 | 2002-12-11 | Kyorin Pharmaceutical Co., Ltd. | Derives de pyrazolopyridylpyridazinone et procede de preparation des ces derniers |
| AR012634A1 (es) | 1997-05-02 | 2000-11-08 | Sugen Inc | Compuesto basado en quinazolina, composicion famaceutica que lo comprende, metodo para sintetizarlo, su uso, metodos de modulacion de la funcion deserina/treonina proteinaquinasa con dicho compuesto y metodo in vitro para identificar compuestos que modulan dicha funcion |
| US6339089B2 (en) | 1997-08-13 | 2002-01-15 | Fujirebio Inc. | Pyrimidine nucleus-containing compound and a medicament containing the same for a blood oxygen partial pressure amelioration, and a method for preparing the same |
| US6329381B1 (en) | 1997-11-28 | 2001-12-11 | Sumitomo Pharmaceuticals Company, Limited | Heterocyclic compounds |
| TW572758B (en) | 1997-12-22 | 2004-01-21 | Sumitomo Pharma | Type 2 helper T cell-selective immune response inhibitors comprising purine derivatives |
| US6187777B1 (en) | 1998-02-06 | 2001-02-13 | Amgen Inc. | Compounds and methods which modulate feeding behavior and related diseases |
| CA2321153A1 (fr) | 1998-02-17 | 1999-08-19 | Timothy D. Cushing | Antiviraux derives de pyrimidine |
| US6110929A (en) | 1998-07-28 | 2000-08-29 | 3M Innovative Properties Company | Oxazolo, thiazolo and selenazolo [4,5-c]-quinolin-4-amines and analogs thereof |
| JP4342007B2 (ja) | 1998-08-10 | 2009-10-14 | 大日本住友製薬株式会社 | キナゾリン誘導体 |
| JP4315300B2 (ja) | 1998-08-10 | 2009-08-19 | 大日本住友製薬株式会社 | 新規なキナゾリン誘導体 |
| EP1110951B1 (fr) | 1998-08-27 | 2004-05-19 | Sumitomo Pharmaceuticals Company, Limited | Derives de pyrimidine |
| US6583148B1 (en) | 1999-04-08 | 2003-06-24 | Krenitsky Pharmaceuticals, Inc. | Neurotrophic substituted pyrimidines |
| CA2323008C (fr) | 1999-10-11 | 2005-07-12 | Pfizer Inc. | Composes pharmaceutiques actifs |
| WO2002088079A2 (fr) | 2001-05-01 | 2002-11-07 | Bristol-Myers Squibb Company | Inhibiteurs doubles de pde 7 et pde 4 |
| AU2002364211A1 (en) | 2001-12-21 | 2003-07-15 | Bayer Pharmaceuticals Corporation | Thienopyrimidine derivative compounds as inhibitors of prolylpeptidase, inducers of apoptosis and cancer treatment agents |
| US7091232B2 (en) | 2002-05-21 | 2006-08-15 | Allergan, Inc. | 4-(substituted cycloalkylmethyl) imidazole-2-thiones, 4-(substituted cycloalkenylmethyl) imidazole-2-thiones, 4-(substituted cycloalkylmethyl) imidazol-2-ones and 4-(substituted cycloalkenylmethyl) imidazol-2-ones and related compounds |
| TW200407143A (en) | 2002-05-21 | 2004-05-16 | Bristol Myers Squibb Co | Pyrrolotriazinone compounds and their use to treat diseases |
| AU2003242252A1 (en) | 2002-06-07 | 2003-12-22 | Kyowa Hakko Kogyo Co., Ltd. | Bicyclic pyrimidine derivatives |
| KR101111085B1 (ko) | 2002-09-27 | 2012-04-12 | 다이닛본 스미토모 세이야꾸 가부시끼가이샤 | 신규 아데닌 화합물 및 그 용도 |
| US8455458B2 (en) | 2002-10-16 | 2013-06-04 | Arthrodynamic Technologies, Animal Health Division, Inc. | Composition and method for treating connective tissue damage |
| MXPA05013922A (es) | 2003-06-20 | 2006-02-24 | Coley Pharm Group Inc | Antagonistas de receptor tipo toll de molecula pequena. |
| WO2005025583A2 (fr) | 2003-09-05 | 2005-03-24 | Anadys Pharmaceuticals, Inc. | Administration de ligands tlr7 et de leurs prodrogues pour traiter l'infection au virus de l'hepatite c |
| TWI392678B (zh) | 2004-03-26 | 2013-04-11 | Dainippon Sumitomo Pharma Co | ９-取代-８-氧基腺嘌呤化合物 |
| WO2005092892A1 (fr) | 2004-03-26 | 2005-10-06 | Dainippon Sumitomo Pharma Co., Ltd. | Compose 8-oxoadenine |
| WO2007084413A2 (fr) | 2004-07-14 | 2007-07-26 | Ptc Therapeutics, Inc. | Procedes de traitement de l’hepatite c |
| WO2006015985A1 (fr) | 2004-08-10 | 2006-02-16 | Janssen Pharmaceutica N.V. | Dérivés de 1,2,4-triazin-6-one inhibiteurs du vih |
| BRPI0517559A (pt) | 2004-11-09 | 2008-10-14 | Hoffmann La Roche | composto, processo para a sua preparação, método para o tratamento terapêutico e/ou profilático de enfermidades que são moduladas por inibidores de ptb-1b e utilização dos compostos |
| US7498409B2 (en) | 2005-03-24 | 2009-03-03 | Schering Corporation | Screening assay for TLR7, TLR8 and TLR9 agonists and antagonists |
| CN101203519A (zh) | 2005-05-04 | 2008-06-18 | 辉瑞有限公司 | 用于治疗癌症和病毒感染如丙型肝炎的用作Toll样受体调节剂的2－酰氨基－6－氨基－8－氧代嘌呤衍生物 |
| AR054122A1 (es) | 2005-05-12 | 2007-06-06 | Tibotec Pharm Ltd | Pirido[2,3-d]pirimidas utiles como inhibidores de hcv, y metodos para la preparacion de las mismas |
| US7994360B2 (en) | 2005-05-16 | 2011-08-09 | Xtl Biopharmaceuticals Ltd. | Benzofuran compounds |
| TW201402124A (zh) | 2005-08-19 | 2014-01-16 | Array Biopharma Inc | 作為類鐸受體（ｔｏｌｌ-ｌｉｋｅ ｒｅｃｅｐｔｏｒ）調節劑之８-經取代苯并氮雜呯 |
| CN101296907B (zh) | 2005-09-01 | 2013-03-27 | 弗·哈夫曼-拉罗切有限公司 | 作为p2x3和p2x2/3调节剂的二氨基嘧啶类 |
| JPWO2007034881A1 (ja) | 2005-09-22 | 2009-03-26 | 大日本住友製薬株式会社 | 新規アデニン化合物 |
| WO2007056208A2 (fr) | 2005-11-02 | 2007-05-18 | Cytovia, Inc. | N-arylalkyl-thienopyrimidin-4-amines et analogues en tant qu'activateurs de caspases et inducteurs d'apoptose et utilisation de ceux-ci |
| WO2007063934A1 (fr) | 2005-12-02 | 2007-06-07 | Mitsubishi Tanabe Pharma Corporation | Compose heterocyclique alicyclique |
| WO2007093901A1 (fr) | 2006-02-17 | 2007-08-23 | Pfizer Limited | Dérivés de 3-déazapurine en tant que modulateurs de tlr7 |
| WO2008009078A2 (fr) | 2006-07-20 | 2008-01-24 | Gilead Sciences, Inc. | Dérivés de la quinazoline tri-substitués en 4,6-dl et en 2,4,6 utilisables pour traiter les infections virales |
| WO2008009077A2 (fr) | 2006-07-20 | 2008-01-24 | Gilead Sciences, Inc. | Dérivés quinazoline 4,6-disubstitués et 2,4,6-trisubstitués et compositions pharmaceutiques utiles pour traiter des infections virales |
| CA2662401A1 (fr) * | 2006-09-15 | 2008-03-20 | Basf Se | Copolymere ampholytique a base de monomeres contenant de l'azote quaternise |
| AR064154A1 (es) | 2006-12-07 | 2009-03-18 | Piramed Ltd | Compuestos inhibidores de fodfoinostida 3- quinasas y composiciones farmaceuticas |
| WO2008075103A1 (fr) | 2006-12-20 | 2008-06-26 | Istituto Di Ricerche Di Biologia Molecolare P. Angeletti Spa | Indoles antiviraux |
| CN101790380B (zh) | 2007-02-07 | 2013-07-10 | 加利福尼亚大学董事会 | 合成tlr激动剂的缀合物及其应用 |
| TW200904437A (en) * | 2007-02-14 | 2009-02-01 | Janssen Pharmaceutica Nv | 2-aminopyrimidine modulators of the histamine H4 receptor |
| JP2008222557A (ja) | 2007-03-08 | 2008-09-25 | Kotobuki Seiyaku Kk | ピロロ［３，２−ｄ］ピリミジン誘導体及びこれを有効成分とする医薬組成物 |
| DK2132209T3 (da) | 2007-03-19 | 2014-04-14 | Astrazeneca Ab | 9-substituerede 8-oxo-adeninforbindelser som modulatorer af tlr7 (toll-like receptor 7) |
| WO2008114819A1 (fr) | 2007-03-20 | 2008-09-25 | Dainippon Sumitomo Pharma Co., Ltd. | Nouveau composé d'adénine |
| TW200902018A (en) | 2007-03-20 | 2009-01-16 | Dainippon Sumitomo Pharma Co | Novel adenine compound |
| EP2152674B1 (fr) | 2007-05-22 | 2011-08-03 | Boehringer Ingelheim International GmbH | Inhibiteurs de benzimidazolone chymase |
| CN101784548B (zh) | 2007-06-29 | 2013-07-17 | 吉里德科学公司 | 嘌呤衍生物及其作为toll样受体7的调节剂的用途 |
| MX2010001650A (es) | 2007-08-10 | 2010-08-02 | Glaxosmithkline Llc | Entidades quimicas biciclicas que contienen nitrogeno para el tratamiento de infecciones virales. |
| WO2009032668A2 (fr) | 2007-08-28 | 2009-03-12 | Irm Llc | Composés et compositions en tant qu'inhibiteurs de kinase |
| WO2009030998A1 (fr) | 2007-09-05 | 2009-03-12 | Coley Pharmaceutical Group, Inc. | Composés pyrimidine utilisés comme agonistes du récepteur de type toll (tlr) |
| PE20091236A1 (es) | 2007-11-22 | 2009-09-16 | Astrazeneca Ab | Derivados de pirimidina como immunomoduladores de tlr7 |
| BRPI0821836A2 (pt) | 2007-12-24 | 2015-06-16 | Tibotec Pharm Ltd | Indóis macrocíclicos como inibidores do vírus da hepatite c |
| AU2009210655B2 (en) | 2008-02-07 | 2013-08-15 | Telormedix Sa | Treatment of bladder diseases with a TLR7 activator |
| US8461107B2 (en) | 2008-04-28 | 2013-06-11 | Merck Sharp & Dohme Corp. | HCV NS3 protease inhibitors |
| US8946239B2 (en) | 2008-07-10 | 2015-02-03 | Duquesne University Of The Holy Spirit | Substituted pyrrolo, -furano, and cyclopentylpyrimidines having antimitotic and/or antitumor activity and methods of use thereof |
| UY31982A (es) | 2008-07-16 | 2010-02-26 | Boehringer Ingelheim Int | Derivados de 1,2-dihidropiridin-3-carboxamidas n-sustituidas |
| CN102482233A (zh) | 2009-05-21 | 2012-05-30 | 阿斯利康(瑞典)有限公司 | 新颖的嘧啶衍生物和它们在治疗癌症和其它疾病中的用途 |
| US8637525B2 (en) | 2009-07-31 | 2014-01-28 | Bristol-Myers Squibb Company | Compounds for the reduction of beta-amyloid production |
| TWI468402B (zh) | 2009-07-31 | 2015-01-11 | 必治妥美雅史谷比公司 | 降低β－類澱粉生成之化合物 |
| US20120232062A1 (en) | 2009-10-20 | 2012-09-13 | Eiger Biopharmaceuticals, Inc. | Azaindazoles to treat flaviviridae virus infection |
| NZ598933A (en) | 2009-10-22 | 2013-04-26 | Gilead Sciences Inc | Derivatives of purine or deazapurine useful for the treatment of (inter alia) viral infections |
| KR101094446B1 (ko) | 2009-11-19 | 2011-12-15 | 한국과학기술연구원 | 단백질 키나아제 저해활성을 가지는 2,4,7-치환된 티에노［3,2-ｄ］피리미딘 화합물 |
| JP2013032290A (ja) | 2009-11-20 | 2013-02-14 | Dainippon Sumitomo Pharma Co Ltd | 新規縮合ピリミジン誘導体 |
| DE102010040233A1 (de) | 2010-09-03 | 2012-03-08 | Bayer Schering Pharma Aktiengesellschaft | Bicyclische Aza-Heterocyclen und ihre Verwendung |
| WO2012067269A1 (fr) | 2010-11-19 | 2012-05-24 | Dainippon Sumitomo Pharma Co., Ltd. | Composés aminoalcoxyphényle et leur utilisation dans le traitement de maladies |
| WO2012066335A1 (fr) | 2010-11-19 | 2012-05-24 | Astrazeneca Ab | Composés phénol en tant qu'agonistes du récepteur 7 de type toll |
| ES2691745T3 (es) | 2011-04-08 | 2018-11-28 | Janssen Sciences Ireland Uc | Derivados de pirimidina para el tratamiento de infecciones víricas |
| EP2709989B8 (fr) | 2011-05-18 | 2018-04-18 | Janssen Sciences Ireland UC | Dérivés de quinazoline pour le traitement des infections virales et d'autres maladies |
| HUE040541T2 (hu) | 2011-11-09 | 2019-03-28 | Janssen Sciences Ireland Uc | Purin-származékok vírusfertõzések kezelésére |
| AU2013218072B2 (en) | 2012-02-08 | 2017-08-31 | Janssen Sciences Ireland Uc | Piperidino-pyrimidine derivatives for the treatment of viral infections |
| ES2860299T3 (es) | 2012-04-24 | 2021-10-04 | Vertex Pharma | Inhibidores de DNA-PK |
| KR102207888B1 (ko) | 2012-07-13 | 2021-01-26 | 얀센 사이언시즈 아일랜드 언리미티드 컴퍼니 | 바이러스 감염증의 치료를 위한 거대환식 푸린 |
| WO2014023813A1 (fr) | 2012-08-10 | 2014-02-13 | Janssen R&D Ireland | Dérivés d'alkylpyrimidine pour le traitement d'infections virales et d'autres maladies |
| EP2712866A1 (fr) | 2012-10-01 | 2014-04-02 | Centre National de la Recherche Scientifique (CNRS) | Dérivés de 1,2,4-triazine pour le traitement d'infections virales |
| EP2903967B3 (fr) | 2012-10-05 | 2020-04-15 | Janssen Sciences Ireland Unlimited Company | Dérivés d'acylaminopyrimidine pour le traitement des infections virales et d'autres maladies |
| EA202090662A3 (ru) | 2012-10-10 | 2020-08-31 | Янссен Сайенсиз Айрлэнд Юси | ПРОИЗВОДНЫЕ ПИРРОЛО[3,2-d]ПИРИМИДИНА ДЛЯ ЛЕЧЕНИЯ ВИРУСНЫХ ИНФЕКЦИЙ И ДРУГИХ ЗАБОЛЕВАНИЙ |
| SG11201503042QA (en) | 2012-11-16 | 2015-06-29 | Janssen Sciences Ireland Uc | Heterocyclic substituted 2-amino-quinazoline derivatives for the treatment of viral infections |
| EP2958900B1 (fr) | 2013-02-21 | 2019-04-10 | Janssen Sciences Ireland Unlimited Company | Dérivés de 2-aminopyrimidine pour le traitement d'infections virales |
| PT2978429T (pt) | 2013-03-29 | 2017-05-24 | Janssen Sciences Ireland Uc | Deaza-purinonas macrocíclicas para o tratamento de infeções virais |
| WO2014207082A1 (fr) * | 2013-06-27 | 2014-12-31 | Janssen R&D Ireland | Dérivés de pyrrolo[3,2-d]pyrimidine pour le traitement des infections virales et autres maladies |
| WO2015014815A1 (fr) | 2013-07-30 | 2015-02-05 | Janssen R&D Ireland | Dérivés de thiéno[3,2-d]pyrimidines destinés au traitement d'infections virales |
| EP3166938A4 (fr) | 2014-07-11 | 2018-01-17 | Northwestern University | Échafaudages 2-imidazolyl-pyrimidine en tant qu'inhibiteurs puissants et sélectifs de l'oxyde nitrique synthase neuronale |
| CA3027471A1 (fr) * | 2016-07-01 | 2018-01-04 | Janssen Sciences Ireland Unlimited Company | Dihydropyranopyrimidines pour le traitement d'infections virales |
-
2017
- 2017-06-30 CA CA3027471A patent/CA3027471A1/fr active Pending
- 2017-06-30 SG SG11201811448RA patent/SG11201811448RA/en unknown
- 2017-06-30 AU AU2017289418A patent/AU2017289418B2/en not_active Ceased
- 2017-06-30 JP JP2018566863A patent/JP7171444B2/ja active Active
- 2017-06-30 WO PCT/EP2017/066307 patent/WO2018002319A1/fr unknown
- 2017-06-30 CN CN201780040796.5A patent/CN109476675B/zh active Active
- 2017-06-30 MA MA045539A patent/MA45539A/fr unknown
- 2017-06-30 EP EP17735472.7A patent/EP3478688A1/fr active Pending
- 2017-06-30 US US16/312,687 patent/US11053256B2/en active Active
-
2018
- 2018-12-26 IL IL263972A patent/IL263972A/en unknown
-
2021
- 2021-06-23 US US17/355,864 patent/US20210387997A1/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| CN109476675A (zh) | 2019-03-15 |
| JP2019524662A (ja) | 2019-09-05 |
| CN109476675B (zh) | 2022-12-09 |
| EP3478688A1 (fr) | 2019-05-08 |
| IL263972A (en) | 2019-01-31 |
| US20210387997A1 (en) | 2021-12-16 |
| WO2018002319A1 (fr) | 2018-01-04 |
| CA3027471A1 (fr) | 2018-01-04 |
| US11053256B2 (en) | 2021-07-06 |
| US20190322678A1 (en) | 2019-10-24 |
| AU2017289418B2 (en) | 2021-06-03 |
| SG11201811448RA (en) | 2019-01-30 |
| JP7171444B2 (ja) | 2022-11-15 |
| AU2017289418A1 (en) | 2019-01-03 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| MA45539A (fr) | Dihydropyranopyrimidines pour le traitement d'infections virales | |
| MA40867A (fr) | Méthodes pour le traitement d'infections virales à filoviridae | |
| MA45192A (fr) | Traitement d'association | |
| MA44083A (fr) | Composés de biarylmonobactame pour le traitement d'infections bactériennes | |
| EP3233878A4 (fr) | Phosphoramidates pour le traitement du virus de l'hépatite b | |
| MA49144A (fr) | Polythérapies pour le traitement du cancer | |
| MA47719A (fr) | Esketamine pour le traitement de la dépression | |
| EP3474863A4 (fr) | Phosphoramidates pour le traitement du virus de l'hépatite b | |
| EP3431105A4 (fr) | Composition médicinale pour le traitement du cancer | |
| MA42819A (fr) | Procédés pour le traitement d'infections virales à arenaviridae et coronaviridae | |
| MA45481A (fr) | Utilisation d'exosomes pour le traitement de maladies | |
| MA55629A (fr) | Compositions d'anticorps pour le traitement de tumeurs | |
| MA48637A (fr) | Polythérapies pour le traitement du cancer | |
| MA50409A (fr) | Polythérapies pour le traitement du cancer | |
| EP3374350A4 (fr) | Composés à base d'hydroxypyridinone et d'hydroxypyrimidinone pour le traitement d'infections bactériennes | |
| EP3541408A4 (fr) | Compositions et méthodes pour le traitement de l'angiogenèse aberrante | |
| EP3344325A4 (fr) | Administration locale de médicaments pour le traitement de l'asthme | |
| MA54925A (fr) | Compositions pour le traitement de troubles acido-basiques | |
| EP3541417A4 (fr) | Immunothérapies d'association pour le traitement du cancer | |
| EP3419639A4 (fr) | Vecteur aav-idua pour le traitement de la cécité associée à la mps i | |
| EP3766497A4 (fr) | Médicament pour le traitement de la toux | |
| MA42999A (fr) | Polythérapie pour le traitement de malignités | |
| EP3430400A4 (fr) | Schémas posologiques pour le traitement d'infections fongiques | |
| MA49576A (fr) | Compositions et méthodes pour le traitement d'infections fongiques | |
| EP3443962A4 (fr) | Dérivé de quinoline pour le traitement du cancer de l'estomac |